1. 2011 http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125288s0000lbl.pdf
2. http://www.accessdatas.fda.gov/drugsatfda_docs/label/2011/125288s0000lbl.pdf
3. Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II study [oral abstract #355];Klintmalm;Am J Transplant,2011
4. http://www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/ManualofPoliciesProcedures/ucm082000.pdf
5. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm192863.htm